NEXENTIS TECHNOLOGIES INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $938.00K.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, issued for services for the quarter ending 2025-09-30 was $714.00K, a 47.52% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, issued for services for the quarter ending 2025-06-30 was $1.96M, a 3889.80% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, issued for services for the quarter ending 2024-09-30 was $484.00K, a 59.83% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, issued for services for fiscal 2025 was $2.86M, a 277.31% increase from fiscal 2024.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, issued for services for fiscal 2024 was $758.00K, a 74.08% decline from fiscal 2023.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, issued for services for fiscal 2023 was $2.92M, a 218.84% increase from fiscal 2022.
- NEXENTIS TECHNOLOGIES INC. stock issued during period, value, issued for services for fiscal 2022 was $917.07K, a 121.54% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-03-31 | $938.00K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $2.86M 10-K · filed 2026-03-31 | |
| 2025-09-30 | $714.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.96M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $758.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $484.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $49.00K 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $24.00K 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $2.92M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $302.82K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $670.24K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $67.61K 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $917.07K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $245.46K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $283.12K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $279.73K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $413.95K 10-K · filed 2023-03-27 | |
| 2021-09-30 | $151.32K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $126.60K 10-Q · filed 2021-11-15 | |
| 2018-12-31 | $20.00K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |